Phase II trial of therapeutic vaccine consisting of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed glioblastoma

被引：0
|
作者：
Bota, Daniela [1 ]
Piccioni, David [2 ]
LaRocca, Renato [3 ]
Duma, Christopher [4 ]
Aiken, Robert [5 ]
Kesari, Santosh [6 ]
Carrillo, Jose [6 ]
Taylor, Thomas [1 ]
Hsieh, Candace [7 ]
Nistor, Gabriel [7 ]
Dillman, Robert [7 ]
机构：
[1] Univ Calif Irvine, Orange, CA 92668 USA
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] Norton Hosp, Louisville, KY USA
[4] Hoag Hosp, Newport Beach, CA USA
[5] Rutgers State Univ, New Brunswick, NJ USA
[6] John Wayne Canc Inst, Santa Monica, CA USA
[7] AiVita Biomed Inc, Irvine, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O22
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PHASE II TRIAL OF IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS PRESENTED BY AUTOLOGOUS DENDRITIC CELL VACCINE
    Bota, Daniela
    Piccioni, David
    Duma, Christopher
    LaRocca, Renato
    Kesari, Santosh
    Carrillo, Jose
    O'Donnell, Robert
    Aiken, Robert
    Hsu, Frank
    Kong, Xiao-Tang
    Taylor, Thomas
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A196 - A196
  • [2] Randomized phase II trial of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed stage III or IV ovarian cancer
    Abaid, Lisa
    Friedman, Richard
    Brown, John
    Mendivil, Alberto
    Beck, Tiffany
    Corr, Bradley
    Randall, Leslie
    Mason, James
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [3] Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
    Dillman, Robert O.
    Nistor, Gabriel I.
    Keirstead, Hans S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [4] PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL
    Bota, Daniela
    Piccioni, David
    LaRocca, R.
    Duma, Christopher
    Kesari, Santosh
    Carrillo, Jose
    O'Donnell, Robert T.
    Aiken, Robert
    Hsu, Frank
    Kong, Xiao-Tang
    Hsieh, Candace
    Langford, Chris
    Carta, Krystal
    Wang, Adrienne
    Langford, James
    Taylor, Thomas
    Nistor, Gabriel
    Dillman, Robert
    NEURO-ONCOLOGY, 2020, 22 : 38 - 39
  • [5] PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1)
    Bota, Daniela A.
    Piccioni, David E.
    Duma, Christopher M.
    LaRocca, Renato V.
    Kesari, Santosh
    Abedi, Mehrdad
    Carrillo, Jose A.
    Aiken, Robert D.
    Hsu, Frank
    Kong, Xiao-Tang
    Taylor, Thomas H.
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    NEURO-ONCOLOGY, 2021, 23 : 58 - 58
  • [6] Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report
    Dillman, Robert O.
    Selvan, Senthamil R.
    Schiltz, Patric M.
    McClay, Edward F.
    Barth, Neil M.
    DePriest, Carol
    de Leon, Cristina
    Mayorga, Cheryl
    Cornforth, Andrew N.
    Allen, Kanoe
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (03) : 311 - 319
  • [7] A phase I clinical trial in patients with newly diagnosed glioblastoma vaccinated with autologous dendritic cells pulsed with autologous tumor lysate.
    Boynton, A. L.
    Prins, R.
    Bosch, M.
    Yang, M.
    Odesa, S. K.
    Khan-Farooqi, H.
    Cloughesy, T.
    Liau, L.
    CYTOTHERAPY, 2006, 8
  • [8] Manufacturing patient-specific autologous dendritic cell vaccines targeting antigens from autologous tumor cells that were self-renewing in liquid cell culture and injecting such vaccines to treat patients with advanced cancer
    Dillman, Robert O.
    Nistor, Gabriel I.
    Keirstead, Hans S.
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [9] Final results of phase 2 trial of personal dendritic cell (DC) vaccines loaded with autologous tumor antigens (ATA) in newly diagnosed glioblastoma (GBM)
    Bota, Daniela Annenelie
    Piccioni, David Eric
    Taylor, Thomas H.
    LaRocca, Renato V.
    Aiken, Robert D.
    Kong, Xiao-Tang
    Lopez, Katrina L.
    Keirstead, Hans S.
    Nistor, Gabriel I.
    Dillman, Robert O.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Self-renewing, Proliferating Autologous Melanoma Cells, Alone or Combined With Dendritic Cells, as Vaccine Immunotherapy for Patients With Metastatic Melanoma: Results of Consecutive Phase II Trials
    Dillman, Robert O.
    Selvan, Senthamil R.
    Cornforth, Andrew N.
    DePriest, Carol
    DeLeon, Cristina
    Mayorga, Cheryl
    Schiltz, Patric M.
    Beutel, Linda D.
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 968 - 968
12345